Literature DB >> 12034149

Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.

Maarten P van den Berg1, Geert Tjeerdsma, Pieter Jan de Kam, Frans Boomsma, Harry J G M Crijns, Dirk J van Veldhuisen.   

Abstract

BACKGROUND: Congestive heart failure (CHF) is characterized by neurohormonal activation, including increased plasma concentrations of atrial natriuretic peptide (ANP) and N-terminal ANP (N-ANP). Onset of atrial fibrillation (AF) further increases these peptides, but it may be hypothesized that concentrations decrease during longstanding AF due to inherent atrial degeneration. AIM: We sought to investigate the relation between neurohormonal activation in patients with CHF and the duration of concomitant AF.
METHODS: The study group comprised 60 patients (age 70 +/- 8 years) with advanced CHF due to left ventricular systolic dysfunction (left ventricular ejection fraction (LVEF) < 0.35) and chronic AF (duration 21 (1-340) months). Plasma neurohormone concentrations were measured, and multiple regression analysis was performed to identify their clinical predictors.
RESULTS: Median plasma neurohormone concentrations were: ANP 113 pmol/l, N-ANP 1187 pmol/l, norepinephrine 496 pg/ml, renin 127 micro units/l, aldosterone 128 pg/ml and endothelin 8.1 pg/ml. Norepinephrine, renin, aldosterone and endothelin were not significantly related to the duration of AF. In contrast, ANP decreased along with the duration of AF (P = 0.03), while the same trend was observed for N-ANP (P = 0.10). However, for these peptides a first order interaction with LVEF was present, which was not observed in the other neurohormones. In patients with LVEF > 0.25 ANP and N-ANP increased along with the duration of AF, whereas in patients with LVEF < or = 0.25 an inverse relation between ANP (P = 0.02) and N-ANP (P = 0.04) and the duration of AF was present, longer-standing AF being associated with lower concentrations.
CONCLUSION: In patients with advanced CHF with low LVEF plasma ANP and N-ANP concentrations decrease during longstanding AF. This finding agrees with the concept that longstanding AF leads to impaired ability of the atria to produce these neurohormones due to inherent degenerative changes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034149     DOI: 10.1016/s1388-9842(01)00232-x

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

1.  Echocardiographic left atrial reverse remodeling after catheter ablation of atrial fibrillation is predicted by preablation delayed enhancement of left atrium by magnetic resonance imaging.

Authors:  Suman S Kuppahally; Nazem Akoum; Troy J Badger; Nathan S Burgon; Thomas Haslam; Eugene Kholmovski; Rob Macleod; Christopher McGann; Nassir F Marrouche
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

Review 2.  CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation.

Authors:  Frank Pelosi; Fred Morady
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

Review 3.  Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

Authors:  Bandar Al Ghamdi; Walid Hassan
Journal:  J Atr Fibrillation       Date:  2009-06-01

4.  Myocardial sleeves of pulmonary veins and atrial fibrillation: a postmortem histopathological study of 100 subjects.

Authors:  Ivo Steiner; Petra Hájková; Jirí Kvasnicka; Ivana Kholová
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

5.  Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment.

Authors:  Antonella Colella; Serena Digiaro; Marco Fiorentino; Beatrice Greco; Mariateresa Sasanelli; Paola Paradies
Journal:  Open Vet J       Date:  2022-06-03

6.  Mechanistic implication of decreased plasma atrial natriuretic peptide level for transient rise in the atrial capture threshold early after ICD or CRT-D implantation.

Authors:  Kojiro Ogawa; Kentaro Yoshida; Yoshiko Uehara; Mari Ebine; Akira Kimata; Hidetaka Nishina; Noriyuki Takeyasu; Yuichi Noguchi; Masaki Ieda; Kazutaka Aonuma; Akihiko Nogami
Journal:  J Interv Card Electrophysiol       Date:  2018-07-17       Impact factor: 1.900

7.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

8.  Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure.

Authors:  S W Jung; W Sun; L G Griffiths; M D Kittleson
Journal:  J Vet Intern Med       Date:  2015-12-17       Impact factor: 3.333

9.  Symptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised interventional component.

Authors:  Emmanouil Charitakis; Ulla Walfridsson; Fredrik Nyström; Eva Nylander; Anna Strömberg; Urban Alehagen; Håkan Walfridsson
Journal:  BMJ Open       Date:  2015-12-21       Impact factor: 2.692

10.  Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillation.

Authors:  Milton Packer
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.